The leading aim was to identify acceptable analytical targets by examining human hepatocyte incubation samples with superior-resolution mass spectrometry (HRMS) and to verify the effects in reliable urine specimens and to determine AB-FUBINACA's metabolic steadiness in human liver microsomes and when compared hepatocyte and urine benefits with in silico predictions. https://heinzm383xod7.theobloggers.com/profile